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Abstract
Background: After completion of curative breast cancer treatment, patients go through a transition from patient to
survivor. During this re-entry phase, patients are faced with a broad range of re-entry topics, concerning physical
and emotional recovery, returning to work and fear of recurrence. Standard and easy-accessible care to facilitate
this transition is lacking. In order to facilitate adjustment for all breast cancer patients after primary treatment, the
BREATH intervention is aimed at 1) decreasing psychological distress, and 2) increasing empowerment, defined as
patients’ intra- and interpersonal strengths.
Methods/design: The non-guided Internet-based self-management intervention is based on cognitive behavioural
therapy techniques and covers four phases of recovery after breast cancer (Looking back; Emotional processing;
Strengthening; Looking ahead). Each phase of the fully automated intervention has a fixed structure that targets
consecutively psychoeducation, problems in everyday life, social environment, and empowerment. Working
ingredients include Information (25 scripts), Assignment (48 tasks), Assessment (10 tests) and Video (39 clips
extracted from recorded interviews). A non-blinded, multicentre randomised controlled, parallel-group, superiority
trial will be conducted to evaluate the effectiveness of the BREATH intervention. In six hospitals in the Netherlands,
a consecutive sample of 170 will be recruited of women who completed primary curative treatment for breast
cancer within 4 months. Participants will be randomly allocated to receive either usual care or usual care plus
access to the online BREATH intervention (1:1). Changes in self-report questionnaires from baseline to 4 (post-
intervention), 6 and 10 months will be measured.
Discussion: The BREATH intervention provides a psychological self-management approach to the disease
management of breast cancer survivors. Innovative is the use of patients’ own strengths as an explicit intervention
target, which is hypothesized to serve as a buffer to prevent psychological distress in long-term survivorship. In
case of proven (cost) effectiveness, the BREATH intervention can serve as a low-cost and easy-accessible
intervention to facilitate emotional, physical and social recovery of all breast cancer survivors.
Trial registration: This study is registered at the Netherlands Trial Register (NTR2935)
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Background
A growing number of women is living with and beyond
breast cancer. The incidence in the Netherlands is
expected to grow with 27% between 2010 and 2020 [1],
and reflects the increasing breast cancer incidence of
women worldwide [2,3]. At the same time, the national
biennial mammographic screening for all women aged
50–75 in the Netherlands has resulted in a decrease in
mortality in women with breast cancer [4]. As a result,
nowadays the majority of women undergo curative treat-
ment and continue to live their life with breast cancer as
a chronic illness. This view of breast cancer as a chronic
illness has implications for follow-up or survivorship
care [5], and poses new challenges to deliver care to the
increasing population of breast cancer survivors (BCS).
The re-entry phase
After the end of primary curative breast cancer treat-
ment, patients go through the transition from ‘patient’
to ‘survivor’ [6,7]. This transition or re-entry phase [8] is
characterized by multiple adaptive tasks on emotional,
physical and social domain and sets stage for adaptive
long-term survivorship [9]. Topics encountered during
the re-entry phase are in principle universal for all BCS
and include among others: physical recovery, emotional
processing, fear of recurrence, decreasing social support
(losing the “safety net” of treatment), resuming profes-
sional activities, but also positive life changes (e.g. valu-
ing life more) [6,7,10-12]. Although the majority of BCS
eventually adjusts well [13,14], there is a high informa-
tion need concerning these topics [15]. However, despite
the high information need and universality of re-entry
topics, standardized and easy-accessible care to facilitate
the transition towards breast cancer survivorship is
lacking.
Interventions during re-entry phase
Research on the effectiveness of psychosocial interven-
tions to improve psychological well-being after comple-
tion of curative breast cancer treatment is still scarce
and inconclusive [10,16]. With regard to the type of
intervention it is suggested that interventions based on
cognitive behavioural therapy (CBT) produce larger ef-
fect sizes than interventions lacking CBT components
[17], and can be effective in reducing distress [18] and
improving quality of life in BCS [16]. Also, a central role
in survivorship care has been proposed for self-
management [5], which is defined as “the individual’s
ability to manage the symptoms, treatment, physical and
psychosocial consequences and life style changes inher-
ent in living with a chronic condition” [19]. First evi-
dence suggests that self-management interventions in
the re-entry phase can facilitate the transition into breast
cancer survivorship. For example, pilot testing of a self-
management intervention with face-to-face and tele-
phone contact (the Taking Charge intervention [20])
showed beneficial effects on dealing with post-treatment
concerns. The Moving Beyond Cancer randomised con-
trolled trial [21] demonstrated beneficial effects of psy-
choeducational print material and peer modeling videos
for BCS on regaining energy in the re-entry phase.
Internet interventions
Evidence is growing that Internet interventions can im-
prove psychological well-being in cancer patients [22].
Compared to other methods of delivery, the Internet
provides an easily accessible opportunity to reach the
large group of cancer survivors. Also, Internet interven-
tions can contain more channels of media to tailor infor-
mation, and can provide more anonymity compared to
face-to-face interventions. Other advantages include
avoiding waiting lists, providing consistency of care, and
a 24-hour availability [23]. Pilot evidence suggests that
an Internet intervention specially designed for posttreat-
ment survivors (Project Onward [24]) can have high
utilization rates and reduce depressive symptoms. How-
ever, despite the large number of women turning to the
Internet for breast cancer-related information [25-27],
evidence-based Internet interventions specifically designed
for BCS in the re-entry phase are lacking.
BREast cancer e-healTH [BREATH]
The BREAst cancer e-healTH [BREATH] intervention
(‘Catching your breath after breast cancer’) is a non-
guided Internet-based self-management website for BCS
aiming to foster adjustment after completion of primary
curative treatment. Self-management interventions are
multi-component and “usually designed to increase the
repertoire of participants’ self-management skills within
the realities of living with a chronic condition” [28]. The
BREATH intervention is a self-management program
based on CBT containing components such as psycho-
education, cognitive reframing, goal planning and
process evaluation. By using the intervention, BCS will
learn how to use these CBT techniques as self-
management skills in their daily lives. The BREATH
intervention has a fixed content and structure, because
it is assumed that “effective self-managers will feel
confident in selecting the techniques(s) that they be-
lieve will meet their specific needs at a given point of
time and in a given environment or situation” [28].
Peer-support is not included in the BREATH inter-
vention, since in the Netherlands support-groups are
already widely accessible on the Internet. Also, scien-
tifically the use of Internet-based support groups in
cancer patients still needs to confirm long-lasting psy-
chological effects [29]. The BREATH intervention is
designed to facilitate and promote adjustment for all
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BCS, both distressed and non-distressed. In concord-
ance with the stress-coping model of Leventhal
(1984), emotional well-being after cancer is defined as
the balance between stress and resources [30]. There-
fore, in order to target these two aspects of emotional
well-being, the aim of the BREATH intervention is
twofold: decreasing psychological distress and increas-
ing psychological empowerment, which reflects the
individual outcome measure of a patients’ intraper-
sonal and interpersonal strengths [31].
Hypotheses of the BREATH trial
The primary objective of this randomised controlled trial
(RCT) is whether the BREATH intervention is effective
compared to usual care in fostering adjustment after
curative breast cancer treatment by reducing psycho-
logical distress and improving empowerment in BCS.
Because BSC with and without elevated levels of psycho-
logical distress are included it is hypothesized that
through using the BREATH intervention:
1) distressed BCS will experience a decrease in
psychological distress,
2) non-distressed BCS will maintain a low level of
distress, and/or
3) both distressed and non-distressed BCS will increase
in empowerment.
Methods/design
In this article, the BREATH study design and interven-
tion will be reported in concordance with the guidelines
of reporting Internet intervention research [22] and the
CONSORT 2010 statement for reporting parallel group
randomised trials [32], and eHealth interventions [33].
Study design
This study is designed as a non-blinded, multicentre
randomised controlled, parallel-group trial evaluating
the superiority of the BREATH intervention compared
to usual care after primary curative breast cancer treat-
ment. A consecutive sample of 170 BCS from 6 hospitals
will be evaluated in this RCT. Baseline measure (T0)
and randomization take place 3 months after completion
of primary curative breast cancer treatment. This start-
ing point was chosen because this is in accordance with
the standard first follow-up visit after completion of pri-
mary treatment as described in the Dutch national
breast cancer guideline. Moreover, these 3 months allow
for the natural recovery of emotional well-being and ad-
justment to take place. After completion of baseline
measure, participants will be randomised to either inter-
vention or control group. Follow-up measures are re-
spectively 4 months (T1; post-intervention), 6 months
(T2), and 10 months (T3) after baseline. The overall
study design is captured in Figure 1.
Participant eligibility
Inclusion criteria are: Women with a histologically
proven malignancy of the breast; breast cancer is treated
with curative intent surgery and adjuvant chemotherapy
and/or radiotherapy; last chemo- or radiotherapy is
received ≥2 and ≤4 months; direct access to a computer
with Internet connection; basic Internet skills (e.g. in
possession of email address); and a good command of
the Dutch language. Exclusion criteria are: Men; breast
cancer treated only with surgery; metastatic breast car-
cinoma; previous malignancy except adequately treated
cervix carcinoma in situ and treated basal cell carcinoma
of the skin; current treatment in psychiatric outpatient
clinic.
Recruitment settings and procedure
Participants will be recruited from the oncology and
radiotherapy outpatient clinic of a university hospital
(Radboud University Medical Centre, Nijmegen), and
oncology outpatient clinics of five regional hospital sites
(Rijnstate hospital, Arnhem and Zevenaar; Slingeland
hospital, Doetinchem; hospital Gelderse Vallei, Ede;
Canisius Wilhelmina hospital, Nijmegen; Jeroen Bosch
hospital; Den Bosch). All hospitals involved in this mul-
ticentre RCT are situated in the southeastern part of the
Netherlands.
Recruitment will take place at the end of curative
treatment. During the last chemotherapy, or first follow-
up visit (3 months after completion of primary treat-
ment) eligible BCS are informed about the BREATH
study by a member of their treatment team (oncologist,
radiotherapist, or nurse). When BCS are interested in
participating in the study, the researcher will have a one-
time telephone contact (15–30 minutes) to provide add-
itional information, address questions and second check
of the eligibility criteria. Participants will complete
informed consent during the next visit at their local hos-
pital, or by mail (depending on the local informed con-
sent procedure of the hospital setting).
Randomization
The unit of randomization in this study is the individual
breast cancer survivor. For each hospital setting, strati-
fied randomization will be based on hormonal therapy.
Adjuvant primary curative breast cancer treatment
involves hormonal therapy in about 75% of all BCS. Dur-
ing hormonal therapy patients report mood swings and
increased fatigue, which can be expected to influence
the relationship between the intervention and the out-
come variable. After stratification for the use of hormo-
nal therapy, for each hospital a randomised block design
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will be used using variable block sizes of 4, 6 and 8 to
ensure blinded allocation concealment. With an online
computerized random number generator, participants
will be randomly allocated to receive either usual care or
usual care plus access to the online BREATH interven-
tion with an allocation ratio of 1:1. Both the participants,
their health care providers, and the researcher are blind
to the allocation sequence, but the participant and the
researcher are not blind for the randomization outcome.
The BREATH intervention
The intervention is developed by the department of
Medical Psychology of the Radboud University Medical
Centre Nijmegen in the Netherlands, with technical as-
sistance for ICT applications from Innovatie Psycholo-
gische en Psychiatrische Zorg (IPPZ), Utrecht in the
Netherlands. The intellectual ownership of the interven-
tion lies with the department of Medical Psychology.
During the development of the intervention, patient par-
ticipation was secured by (filmed) interviews with
patients, content feedback by a multidisciplinary reading
committee, including BCS and oncology professionals,
and usability testing of the final website.
Intervention content and structure
The non-guided Internet-based self-management BREATH
intervention uses CBT techniques and guides BCS
chronologically through the transition from ‘breast can-
cer patient’ to ‘survivor’. It is a preventive, early-
intervention program that is available to all BCS and
does not require screening. The protocol has a fixed
structure that covers four months, representing four
different phases of recovery after breast cancer: 1) Look-
ing back [‘Terugkijken’], 2) Emotional Processing
[‘Verwerken’], 3) Strengthening [Versterken’], and 4)
Looking ahead [‘Vooruit kijken’]. These four phases are
Baseline
4 months
6 months
10months
Figure 1 Overall study design of the BREATH study.
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visually recognizable on the homepage of the interven-
tion (see Figure 2). Each phase equals one month and
has a fixed structure that covers four weeks, targeting
consecutively psychoeducation, problems in everyday
life, social environment, and empowerment. Universal
re-entry topics for recovery after curative breast cancer
treatment are organized within the fixed structure of
the 16-week intervention (see Table 1 for some exam-
ples). At the start of the intervention, only the first week
is available. During the course of the intervention, every
week new information is unlocked and available to
patients. The prescribed use of the intervention is one
hour per week, which is a total exposure of 16 hours
during the course of the four months of the interven-
tion. However, no conditions are attached to the use or
the time investment of the intervention. It is up to the
BCS how and to what extent they use the intervention.
Intervention functionalities
The most important functionalities of the BREATH
intervention are the phase and week overview. Other
functionalities include a library with background infor-
mation, a personal notebook and a mailbox for technical
assistance. Each week overview is filled with working
ingredients surrounding a re-entry topic. Working ingre-
dients include Information (25 scripts), Assignment
(total 48 tasks), Assessment (total 10 tests) and Video
(39 clips). Being a self-management program, the focus
of the multi-modal intervention is on the information
and the assignments. Assignments are for example writ-
ing tasks, social engagement or conversation tasks and
aim to increase skill-building. Other elements of pro-
gram interactivity included in the BREATH intervention
are assessments or tests to be used by the patient as a
screening instrument of potential problems. Tests are
for example on topics concerning depressive mood after
breast cancer treatment, fear of recurrence, and post-
treatment fatigue. The tests are followed by automated
feedback using a traffic light model (green-orange-red),
with red illustrating elevated symptoms including the
advice to contact a professional. The videos in the
BREATH intervention are extracted clips from recorded
Figure 2 Screenshot of the BREATH intervention with four-month phase structure.
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interviews with three women who completed curative
breast cancer treatment. The women in these peer mod-
eling videos are of different ages and social backgrounds
to increase recognition and empathy of the heteroge-
neous group of BCS.
Support
The BREATH intervention is fully-automated and non-
guided and is delivered without professional support of a
therapist. Human support is only available for technical
assistance by the researcher. Through email, the re-
searcher can be contacted and availability of this support
is only during work-week and hours (Monday-Friday/
9 am-6 pm). During the first login, a welcome page
opens automatically with a demonstration video to se-
cure basic knowledge of intervention functionality. The
demonstration video stays available in the library of the
intervention. Every week and on pre-specified times,
standardized emails are sent to intervention users as a
reminder that they have access to a new week of infor-
mation. These support emails intend to reduce attrition
by reminding users to return to and use the BREATH
intervention [22].
Privacy
Intervention users are registered by the researcher and
receive a unique user name and automated password
(changeable later). Patients receive an invitation email
with a statement of acceptance of conditions of use. The
researcher has access to view the profile of the patient
and the identity of the researcher is visible to the
patient.
Usual care
The control group of this RCT has access to usual care.
The control condition reflects the natural course of re-
covery after curative breast cancer treatment. In the
Netherlands, standard follow-up of breast cancer
involves appointments every three months with a med-
ical professional. The control group may freely use infor-
mation about breast cancer on the Internet, but does
not have access to the protected website with the
BREATH intervention.
Study outcome measures
Demographic characteristics will be gathered by self-
report using questionnaires. Information on diagnosis
will be obtained from the patient’s physician and medical
record. Questionnaires are filled out online with Rad-
Quest software (developed by the department of Medical
Psychology, Radboud University Medical Centre, Nijmegen).
Participants will receive an invitational email with a link
to complete the questionnaires. For an elaborate over-
view of primary and secondary outcome measures, see
Table 2.
Primary outcomes
Psychological distress will be assessed with the Symptom
Checklist 90-items (SCL-90). The SCL-90 covers a broad
range of psychological functioning from healthy persons
Table 1 Thematic content and structure of the BREATH intervention
PHASE/MONTH WEEK
Psychoeducation Problems in everyday life Social environment Empowerment
1. Looking
back
• Getting started • Emotional effects of breast
cancer diagnosis and treatment
• Breast cancer within the
family
• Personal strengths
• Self-help contract • Explanation of CBT • Reactions of children • Resources of strength
• Personal intervention
goals
• Reactions of partner
2. Emotional
processing
• Coping with life
events
• Coping with breast cancer • Social support • Knowledge as power
• Inventory of previous
life events
• Personal grief • Personal support network • Coping with information
• Sexuality • Relaxation
3. Strengthening • Physical consequences
after breast cancer
treatment
• Dealing with physical
consequences
• Return to work • Balancing strengths
• Building up physical activity • Talking about breast cancer
at work
• Spirituality
4. Looking
ahead
• Personal change after
breast cancer
• Fear of recurrence • Communication with care
providers
• Future after breast
cancer treatment
• Coping with fear
• Recovery as priority • Patient role less central • Ahead on your own
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to psychiatric patients and has good reliability, discrim-
inant validity [34] and is sensitive to change through
psychological intervention [35,36]. By using the SCL-90,
minor changes in psychological functioning of less dis-
tressed BCS can be assessed.
Psychological empowerment will be measured with the
Cancer Empowerment Questionnnaire (CEQ). The CEQ
measures psychological empowerment as an outcome of
empowerment processes in the individual patient [31].
The CEQ presumes that people with cancer can derive
strength from themselves (intrapersonal subscale; Per-
sonal Strength), as well as from their social surroundings
(interpersonal subscales; Social Support, Health Care,
Community) [37].
Secondary outcomes
Anxiety and depressive states will be assessed with the
Hospital Anxiety and Depression Scale (HADS) [38],
which has shown good reliability and validity in onco-
logical settings [39,40], Dutch medical patients [41], and
BCS [42].
Quality of life related to breast cancer will be mea-
sured with the Dutch version of the European
Organization for Research and Treatment of Cancer
(EORTC) Quality of Life Questionnaire Core 30 (QLQ-
C30) [43] and Breast Cancer Module (QLQ-BR23) [44].
Both questionnaires have demonstrated good psycho-
metric properties in BCS [45,46].
General distress will be measured with the Dutch ver-
sion of the Distress Thermometer (DT) [47]. The one-
item screening tool (thermometer) has proven good sensitivity
and specificity in breast cancer patients [48,49].
Illness perceptions will be assessed with the Illness
Cognitions Questionnaire (ICQ) [50], which has good
psychometric properties in patients with chronic medical
conditions [50,51].
Remoralization refers to the restoration of morale (in
this study after the completion of breast cancer treat-
ment) and will be measured with the Remoralization
Scale (RS) [52].
Personal control over life in general, or sense of mas-
tery, will be measured with the Mastery Scale [53],
which has shown to be a predictor of psychological ad-
justment in the year following a breast cancer diagnosis
[13,54].
Positive adjustment following breast cancer will be
measured with the Positive Adjustment Questionnaire
(PAQ) [55].
Coping with the experience of breast cancer will be
measured with the Dutch version of the Impact of Event
Scale (IES) [56-58] and the Brief COPE [59,60].
Self-efficacy with regard to complaints (in this study as
a result of breast cancer) will be measured with the Self-
Efficacy Scale (SES), which has previously been used to
assess self-efficacy concerning post-cancer fatigue
[61,62].
Fear of cancer recurrence and the impact of cancer
worries on daily life will be measured with the Dutch
extended version [63,64] of the Cancer Worry Scale
(CWS) [65,66] and the Cancer Acceptance Scale (CAS)
[64,67].
Fatigue will be measured with the fatigue severity sub-
scale of the Checklist Individual Strength (CIS-fatigue),
which has good psychometric properties in cancer survi-
vors [36].
Family communication about breast cancer will be
measured with a modified version of the Openness to
Discuss Hereditary Cancer in the Family (ODHCF) scale
[68,69]. For this study, the ODHCF was adapted for
women who completed curative breast cancer treatment.
Personality factors will be measured with the Dutch
version [70] of the Big Five Inventory (BFI) [71].
The costs of health care utilization will be collected
through a modified version of the Trimbos/iMTA ques-
tionnaire for Costs associated with Psychiatric illness
(TiC-P) [72]. Questions about the use of breast cancer-
specific medication and care are added to the first part
of the TiC-P concerning direct costs of mental health
care and medicine utilization.
Process outcomes
For the BCS in the experimental group, technical data
on the use of the BREATH intervention will be collected
in addition to the standardized questionnaires. Because
the actual use of this newly developed intervention in
everyday life is unclear, usage variables are recorded to
reflect the actual exposure to the intervention content.
Frequency and duration of logins, website activity, and
other significant usage statistics will be evaluated [73].
Other outcomes
For all patients, medical disease-specific data will be pro-
vided by the hospital where the patient is recruited, or
will be collected from the (electronic) medical record by
the researcher. Also, in the post-treatment (T1) measure,
a question on breast-cancer specific Internet use will be
listed.
Sample size calculation
Based on the two primary outcomes of the BREATH
study, effect on patient level is defined as a decrease in
psychological distress (as measured with the SCL-90) or
an increase in empowerment (as measured with the
CEQ). Therefore, effectiveness of the BREATH interven-
tion is demonstrated when one of the two effects is sig-
nificant. Sample size calculation is based on the SCL-90,
since the SCL-90 has proven sensitive to change through
psychological face-to-face intervention in fatigued cancer
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Table 2 Primary and secondary outcome measures of the BREATH study
Questionnaires Response format Example questions Timepoints
Primary outcome measures
Psychological
distress
Symptom Checklist 90
(90 items)
5 point Likert scale During the past 7 days about how much
were you distressed or bothered by:
T0; T1; T2; T3
• Anxiety (10 items) * range 90–450 *Feeling fearful (anx)
• Agoraphobia (7 items)
• Depression (16 items) * Feelings of worthlessness (depr)
• Somatisation (12 items) * Numbness or tingling in parts of your
body (som)
• Obsessive-compulsive
behaviour (9 items)
• Interpersonal sensitivity
(18 items)
* Feeling that people are unfriendly of
dislike you (int.sens)
• Hostility (6 items) * Nervousness or shakiness inside (anx)
• Sleep (3 items)
Psychological
empowerment
Cancer Empowerment
Questionnaire (40 items)
5 point Likert scale T0; T1; T2; T3
• Personal strength (19 items) * range 40-200 * I know what I am good at (pers.str)
• Social support (9 items) * The people around me take me for
who I am (soc.sup)
• Community (6 items) * In our society people with breast
cancer are considered wholly (com)
• Health care (6 items) * My health care professionals are there
when I need them (h.care)
Secondary outcome measures
Anxiety and
depressive
states
Hospital Anxiety and Depression
Scale (14 items)
4 point Likert scale During the past week: T0; T1; T2; T3
• Anxiety (7 items) * range 0-21 (subscales) * I am restless and can’t keep still (anx)
• Depression (7 items) * range 0-42 (total) * I feel miserable and sad (depr)
Breast cancer-
related quality
of life
EORTC-C30 (30 items) 4 point Likert scale During the past week: T0; T1; T2; T3
• Functional scales (physical,
role, emotional, social, and
cognitive functioning - 15
items)
* range 15-60 * Has your physical condition interfered
with your family life? (role.func)
• Symptom scales (fatigue, pain,
nausea/vomiting - 7 items)
* range 7-28 * Have you had difficulties remembering
things? (cog.func)
• Single symptom items
(6 items)
* range 6-24 7-point linear
analogue scale; range 2-14
* Did pain interfere with your daily
activities? (pain)
• Global health and global
quality of life (2 items)
* How would you rate your overall
quality of life during the past week?
EORTC-BR23 (23 items) 4 point Likert scale During the past week: T0; T1; T2; T3
• Functional scales (body
image, sexual functioning,
sexual enjoyment, future
perspective - 8 items)
* range 8-32 * Did you find it difficult to look
at yourself naked? (body.im)
van den Berg et al. BMC Cancer 2012, 12:394 Page 8 of 13
http://www.biomedcentral.com/1471-2407/12/394
Table 2 Primary and secondary outcome measures of the BREATH study (Continued)
• Symptom scales (arm
symptoms, breast symptoms,
systemic therapy side
effects, upset by hair loss -
15 items)
* range 15-60 * Did you have a swollen arm or
hand? (arm.symp) During the past
4 weeks:
* To what extent were you interested
in sex? (sex.enj)
General
distress
Distress Thermometer
(1 item)
11 point Likert scale T0; T1
* range 0-10 * Circle the number that best describes
how much distress you have been
experiencing in the past week including
today.
Remoralization Remoralization Scale
(12 items)
4 point Likert scale T0; T1
* range 12-48 * I am in control of my life
* I take a positive attitude toward myself
Personal
control
Mastery scale (7 items) 5 point Likert scale T0; T1; T2; T3
* range 7-35 * What happens to me in the future
mostly depends on me
Positive
adjustment
to cancer
Positive Adjustment
Questionnaire
(39 items)
1-7 scale Since you found out about your illness: T0; T1; T2; T3
• Fulfilment (9 items) * range 9-63 * My life is not limited by my illness (ful)
• Re-evaluation (9 items) * range 9-63 *I see life differently (re-ev)
• New ways of living (10 items) * range 10-70 * I can take things more in my stride
(new.w)
• Valuing life (7 items) * range 7-49 * I value life a lot more now (val)
Coping
with the
experience
of cancer
Impact of Event Scale 4 point Likert scale T0; T1
• Intrusion (7 items) * range 13-52 * I had dreams about it (intr)
• Avoidance (8 items) * I tried not to think about it (avoid)
* I tried not to talk about it (avoid)
Brief COPE (28 items) 4 point Likert scale T0; T1
• Active coping (2 items) * range 0-6 (subscales) * I’ve been taking action to try to
make the situation better (act.cop)
• Planning (2 items) * I’ve been learning to live with it (acc)
• Positive reframing (2 items) * I’ve been giving up to attempt to
cope (behav.dis)
• Acceptance (2 items)
• Humor (2 items)
• Religion (2 items)
• Using emotional support
(2 items)
• Using instrumental support
(2 items)
• Self-distraction (2 items)
• Denial (2 items)
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Table 2 Primary and secondary outcome measures of the BREATH study (Continued)
• Venting (2 items)
• Substance use (2 items)
• Behavioral disengagement
* I’ve been criticizing myself (self-bl)
• (2 items)
• Self-blame (2 items)
Self-efficacy Self Efficacy Scale (7 items) 4 point Likert scale T0; T1
* range 7-28 * Whatever I do, I cannot change my
complaints
* I think I could positively influence my
complaints
Fear
of cancer
recurrence
Cancer Worry Scale
(8 items)
4 point Likert scale During the past month: T0; T1; T2; T3
* range 8-32 * How often have you thought about
your chance of getting cancer (again)?
* Have these thoughts affected your
mood?
Cancer Acceptance Scale
(2 items)
4 point Likert scale T0; T1
* range 2-8 * I worry about the cancer returning
* I am anxious about my health
Fatigue
Severity
Checklist Individual Strength 7-point Likert scale T0; T1; T2; T3
• subscale Fatigue Severity
(8 items)
* range 8-56 * I feel tired
* I am rested
* Physically I feel exhausted
Family
communication
ODHCF (14 items) 5 point Likert scale T0; T1; T2; T3
• Nuclear family (7 items) * range 7-35 (subscales)
(or less if not applicable; no
partner/ children/ parents/
siblings)
* My partner doesn’t (nucl.fam) /
parents don’t (fam.or) want me to talk
about breast cancer
• Family of origin (7 items) * My children (nucl.fam) / siblings
(fam.or) often don’t know what to say
or do, when I’m feeling down because
of breast cancer.
Illness
perceptions
Illness Cognition Questionnaire
(18 items)
4 point Likert scale
• Helplessness (6 items) * range 6-24 (subscales) * My illness controls my life (help) T0; T1; T2; T3
• Acceptance (6 items) * I can accept my illness well (acc)
• Perceived benefits (6 items) * I have learned a great deal from my
illness (perc.ben)
Personality Big Five Inventory (44 items) 5 point Likert scale I see myself as someone who: T0; T1
• Neuroticism (8 items) * range 1-5 (subscales) * Worries a lot (neu)
• Extraversion (8 items) * Is full of energy (ext)
• Openness to experience
(10 items)
* Tends to be disorganized (con)
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survivors [36] and information on sensitivity to change
of the CEQ is unknown. Significance level of the sample
size calculation was adjusted to p ≤ 0.25 to keep the
overall chance for type-I errors on 5%. To detect a sig-
nificant difference (0.25) with 80% power between inter-
vention and control group on the SCL-90, a sample size
of 128 BCS (64 in each group) is needed. This sample
size calculation is based on a medium effect size of 0.50
of the BREATH intervention, which has proven to be a
high effect size for non-guided psychological interven-
tions [74]. Based on a systematic review on attrition in
randomised controlled trials of Internet interventions for
anxiety and depression [75], we take into account a 25%
study drop-out rate. This results in a maximal sample
size of 170 BCS that need to be included in the
BREATH trial in case of considerable drop-out.
Statistical analysis
A general linear model for repeated measurements (by the
method of mixed linear model) will be used to analyze the
effect of the BREATH intervention on the two primary
outcome variables (distress and empowerment). Chi square
(categorical variables), ANOVA (normally distributed con-
tinuous variables), and Kruskall-Wallis (non-parametric
variables) will be used to asses baseline characteristics be-
tween groups. Analysis will be done according to
intention-to-treat methodology.
Time line of the BREATH study
Recruitment of participants began in 2010. Primary end-
points (baseline T0 and post-intervention T1) and all
follow-up measures (T2-T3) are expected to be com-
pleted in January 2013.
Ethical issues
The BREATH study has been approved by the Medical
Ethics Committee (CMO) of the Radboud University
Medical Centre, Nijmegen in the Netherlands (CMO
protocol number 2009/144) [see additional file 1]. The
study has also been approved an registered by the local
ethical committees of each hospital setting. Registration
number of the Netherlands Trial Register is NTR2935.
Discussion
This study will evaluate the effectiveness of a non-guided
Internet-based self-management intervention for BCS to
decrease psychological distress and increase empower-
ment. To the best of our knowledge, this is the first online
self-management intervention specially designed for the
BCS after completion of primary breast cancer treatment.
Using the Internet, the BREATH intervention provides a
novel and easy-accessible approach to reduce at an early
stage the impact of psychological problems that may arise
after the completion of medical treatment. In the long term
this study may contribute to early prevention of psycho-
logical problems in BCS. The BREATH study is innovative
in the field of psycho-oncological intervention research.
The results of this study will provide novel insights in
whether common-used CBT-techniques can foster
patients’ own strengths towards adjustment to breast can-
cer. Also, whether it is possible to address both distressed
and non-distressed BCS with the same intervention and
without guidance of a psychologist, or other health care
professional.
When effective, the BREATH intervention will be imple-
mented in follow-up care of BCS. However, in light of the
results of the RCT and experiences of the participants it is
possible that the content, dose or structure of the interven-
tion will have to be adjusted. For conducting high quality
research, we have chosen to offer the BREATH intervention
in a structured way with new information being disclosed
every week. This trial will provide information on whether
BCS prefer a more flexible approach and access to the en-
tire intervention content. Also, the results of this study will
Table 2 Primary and secondary outcome measures of the BREATH study (Continued)
• Conscientiousness (9 items) * Is considerate and kind to almost
everyone (agr)
• Agreeableness (9 items)
Health care
utilization
Trimbos/iMTA questionnaire
for Costs associated with
Psychiatric illness (TiC-P)
Since completion of primary curative
breast cancer treatment (T0) / In the
past four months (T1; T3) / In the past
two months (T2):
T0; T1; T2; T3
• Contacts with medical or
mental health care
professionals (14 items)
Yes/no; frequency * Did you visit a psychologist? (con)
• Hospitalization (1 item) Yes/no; reason Yes/no; dose
and frequency
* Did you use antidepressants? (med)
• Use of breast cancer-
specific, psychiatric and
other medication (8 items)
Yes/no; costs * Did you take part in a breast cancer
rehabilitation program? (other)
• Other costs (10 items)
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have to show whether three months after completion of
primary breast cancer treatment is the right time point to
start with online self-management. Last, the results of this
multicentre RCT will provide insights in who benefits from
BREATH, or which subgroups of BCS gain most effect of
the intervention. Information on subgroups might lead to
personalizing psychosocial cancer treatment in future sur-
vivorship care of breast cancer survivors. The BREATH
intervention provides a minimal intervention that can fill
the gap between the needs and availability of psychosocial
support after breast cancer treatment.
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